LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.

FDA Device Recall #Z-0162-2027 - Class III, September 4, 2026

Recall Summary

Recall Number Z-0162-2027
Classification Class III, Low risk
Date Initiated September 4, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Magellan Diagnostics, Inc.
Location North Billerica, MA
Product Type Devices
Quantity 321 units

Product Description

LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.

Reason for Recall

In kit sub-lot 2530M-01 the date of expiration printed on the outer labeling may indicate the wrong expiration date of July 22, 2026 while the correct expiration date is July 13, 2026. If used the system will display an error message and prevent the operator from running the test. Resulting in delayed results.

Distribution Pattern

US Nationwide distribution in the states of CA, IN, PA, TX, NE, IL, MA, MO, KY.

Lot / Code Information

Model/Catalog Number: 70-6762. UD-DI: 00850355006000. Lot Number. 2530M-01.

Other Recalls from Magellan Diagnostics, Inc.

Recall # Classification Product Date
Z-1893-2026 Class II (1)(2) LeadCare¿ II Blood Lead Test Kit, (3)Lea... Mar 13, 2026
Z-1894-2026 Class II LeadCare¿ Plus Blood Lead Test Kit; Catalog Nu... Mar 13, 2026
Z-1895-2026 Class II LeadCare Ultra Blood Lead Test Kit; Catalog Nu... Mar 13, 2026
Z-0584-2026 Class II The LeadCare¿ II Blood Lead Test System relies ... Feb 23, 2024
Z-0219-2024 Class II LeadCare II Blood Lead Test Kit-For in vitro di... Sep 19, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.